10x Genomics (TXG) Change in Account Payables (2018 - 2026)

10x Genomics has reported Change in Account Payables for 9 years, with the latest figure at $4.8 million in Q1 2026.

• Quarterly Change in Account Payables rose 287.75% year-over-year to $4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (up 149.63% YoY) and the FY2025 annual result came in at -$2.1 million, up 36.61% from the prior year.
• Change in Account Payables climbed to $4.8 million in Q1 2026 per TXG's latest filing, from -$5.4 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $7.4 million in Q2 2022 and troughed at -$13.4 million in Q4 2024.
• A 5-year average of -$50411.8 and a median of -$196000.0 in 2025 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2022 and 2023: Change in Account Payables jumped 729.22% in 2022, then slumped 1331.25% in 2023.
• Over 5 years, Change in Account Payables stood at -$224000.0 in 2022, then plunged by 1331.25% to -$3.2 million in 2023, then tumbled by 317.9% to -$13.4 million in 2024, then surged by 59.56% to -$5.4 million in 2025, then jumped by 188.26% to $4.8 million in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered $4.8 million, -$5.4 million, and -$196000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.